Switch theme
Sign up to access all valuation multiples
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
2005
867
LTM Revenue $663M
LTM EBITDA $50.2M
$2.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Alphatec Holdings has a last 12-month revenue (LTM) of $663M and a last 12-month EBITDA of $50.2M.
In the most recent fiscal year, Alphatec Holdings achieved revenue of $612M and an EBITDA of -$53.9M.
Alphatec Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Alphatec Holdings valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $663M | XXX | $612M | XXX | XXX | XXX |
| Gross Profit | $462M | XXX | $424M | XXX | XXX | XXX |
| Gross Margin | 70% | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $50.2M | XXX | -$53.9M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | -9% | XXX | XXX | XXX |
| EBIT | -$119M | XXX | -$123M | XXX | XXX | XXX |
| EBIT Margin | -18% | XXX | -20% | XXX | XXX | XXX |
| Net Profit | -$145M | XXX | -$162M | XXX | XXX | XXX |
| Net Margin | -22% | XXX | -27% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $437M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Alphatec Holdings's stock price is $12.
Alphatec Holdings has current market cap of $1.8B, and EV of $2.2B.
See Alphatec Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.2B | $1.8B | XXX | XXX | XXX | XXX | $-0.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Alphatec Holdings has market cap of $1.8B and EV of $2.2B.
Alphatec Holdings's trades at 3.7x EV/Revenue multiple, and -41.7x EV/EBITDA.
Equity research analysts estimate Alphatec Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Alphatec Holdings has a P/E ratio of -12.5x.
See valuation multiples for Alphatec Holdings and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV (current) | $2.2B | XXX | $2.2B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | 44.7x | XXX | -41.7x | XXX | XXX | XXX |
| EV/EBIT | -18.8x | XXX | -18.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -12.5x | XXX | -11.2x | XXX | XXX | XXX |
| EV/FCF | -30.1x | XXX | -16.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAlphatec Holdings's last 12 month revenue growth is 19%
Alphatec Holdings's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.6M for the same period.
Alphatec Holdings's rule of 40 is -4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Alphatec Holdings's rule of X is 56% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Alphatec Holdings and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | -9% | XXX | XXX | XXX |
| EBITDA Growth | 99% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -4% | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 56% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 89% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Alphatec Holdings acquired XXX companies to date.
Last acquisition by Alphatec Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Alphatec Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Alphatec Holdings founded? | Alphatec Holdings was founded in 2005. |
| Where is Alphatec Holdings headquartered? | Alphatec Holdings is headquartered in United States of America. |
| How many employees does Alphatec Holdings have? | As of today, Alphatec Holdings has 867 employees. |
| Who is the CEO of Alphatec Holdings? | Alphatec Holdings's CEO is Mr. Patrick S. Miles. |
| Is Alphatec Holdings publicy listed? | Yes, Alphatec Holdings is a public company listed on NAS. |
| What is the stock symbol of Alphatec Holdings? | Alphatec Holdings trades under ATEC ticker. |
| When did Alphatec Holdings go public? | Alphatec Holdings went public in 2006. |
| Who are competitors of Alphatec Holdings? | Similar companies to Alphatec Holdings include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Alphatec Holdings? | Alphatec Holdings's current market cap is $1.8B |
| What is the current revenue of Alphatec Holdings? | Alphatec Holdings's last 12 months revenue is $663M. |
| What is the current revenue growth of Alphatec Holdings? | Alphatec Holdings revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Alphatec Holdings? | Current revenue multiple of Alphatec Holdings is 3.4x. |
| Is Alphatec Holdings profitable? | Yes, Alphatec Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Alphatec Holdings? | Alphatec Holdings's last 12 months EBITDA is $50.2M. |
| What is Alphatec Holdings's EBITDA margin? | Alphatec Holdings's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Alphatec Holdings? | Current EBITDA multiple of Alphatec Holdings is 44.7x. |
| What is the current FCF of Alphatec Holdings? | Alphatec Holdings's last 12 months FCF is -$74.5M. |
| What is Alphatec Holdings's FCF margin? | Alphatec Holdings's last 12 months FCF margin is -11%. |
| What is the current EV/FCF multiple of Alphatec Holdings? | Current FCF multiple of Alphatec Holdings is -30.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
